Related Experiment Video
Updated: Dec 29, 2025

Aip1p Dynamics Are Altered by the R256H Mutation in Actin
Published on: July 30, 2014
ALS-causing D169G mutation disrupts the ATP-binding capacity of TDP-43 RRM1 domain
1Department of Biological Sciences, Faculty of Science, National University of Singapore, 10 Kent Ridge Crescent, 119260, Singapore.
Abstract:
TDP-43 inclusion is a pathological hallmark for ∼97% ALS and ∼45% FTD patients. So far, >50 ALS-causing mutations have been identified, most of which are hosted by the intrinsically-disordered prion-like domain. The D169G mutation is the only one within the well-folded RRM1 domain, which, however, induces no significant change of the crystal structure and even slightly enhances the thermodynamic stability. Therefore, the mechanism for D169G to enhance the cytotoxicity remains elusive. Here by NMR, we reveal for the first time: 1) D169G does trigger significant dynamic changes for a cluster of residues. 2) Very unexpectedly, D169G disrupts the ATP-binding capacity of RRM1 although the ATP-binding pocket is on the back side of the mutation site. Taken together with our previous results, the current study provides a potential mechanism to rationalize enhancement of the TDP-43 cytotoxicity by D169G and highlights again the key roles of ATP in neurodegenerative diseases and ageing.
Insights
The D169G mutation in TDP-43 enhances cytotoxicity in neurodegenerative diseases like ALS and FTD by altering protein dynamics and disrupting ATP binding, despite not changing its structure.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- TDP-43 protein aggregation is a key marker in Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
- Most ALS-associated mutations are in the intrinsically disordered prion-like domain of TDP-43.
- The D169G mutation in the RRM1 domain is unique as it doesn't alter crystal structure or stability, leaving its cytotoxic mechanism unclear.
Purpose of the Study:
- To elucidate the mechanism by which the D169G mutation enhances TDP-43 cytotoxicity.
- To investigate the dynamic and functional changes induced by the D169G mutation in the TDP-43 RRM1 domain.
Main Methods:
- Nuclear Magnetic Resonance (NMR) spectroscopy was employed to study the TDP-43 RRM1 domain with the D169G mutation.
- Analysis focused on residue dynamics and ATP-binding capacity.
Main Results:
- The D169G mutation induces significant dynamic changes in a cluster of residues within the RRM1 domain.
- Unexpectedly, the D169G mutation impairs the ATP-binding capability of the RRM1 domain, despite the mutation site being distant from the ATP-binding pocket.
Conclusions:
- The study proposes a mechanism where D169G-induced dynamic alterations and disrupted ATP binding contribute to TDP-43 cytotoxicity.
- This highlights the critical role of ATP in neurodegenerative diseases and aging processes.
More Related Videos
Related Concept Videos
ATP Synthase: Mechanism
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
ATP Synthase: Structure

